Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001178913-19-001086
Filing Date
2019-04-08
Accepted
2019-04-08 16:17:26
Documents
1
Period of Report
2019-04-08

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT zk1922908.html 4  
1 OWNERSHIP DOCUMENT zk1922908.xml 4 6554
  Complete submission text file 0001178913-19-001086.txt   8151
Mailing Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 5 HAIFA L3 3508409
Business Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 5 HAIFA L3 3508409 972-74-710-7171
PLURISTEM THERAPEUTICS INC (Issuer) CIK: 0001158780 (see all company filings)

EIN.: 980351734 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 63 RABUTZKY STREET RAANANA L3 43220
Business Address
Aberman Zami (Reporting) CIK: 0001344740 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31392 | Film No.: 19737624